Understand the source comparison
5-Amino-1MQ vs Tesofensine — Mechanisms & Research Findings
Research published by Cornell Medical College in 2022 identified NNMT (nicotinamide N-methyltransferase) as a critical regulator of NAD+ availability in adipose tissue. The enzyme that 5-Amino-1MQ specifically inhibits to restore metabolic function at the cell
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Research published by Cornell Medical College in 2022 identified NNMT (nicotinamide N-methyltransferase) as a critical regulator of NAD+ availability in adipose tissue. The enzyme that 5-Amino-1MQ specifically inhibits to restore metabolic function at the cellular level. Tesofensine, meanwhile, operates through an entirely different mechanism: triple monoamine reuptake inhibition that reduces caloric intake by 25–30% through enhanced satiety signaling. The confusion between these compounds stems from their shared association with weight management research, but their biological pathways don't overlap.
- Our team has worked with research institutions evaluating both compounds in metabolic studies. The distinction matters: selecting the wrong compound for a given research question wastes time and compounds. One targets energy production efficiency, the other targets central appetite regulation.
- What is the difference between 5-Amino-1MQ and tesofensine?
- 5-Amino-1MQ is a small-molecule NNMT inhibitor that restores NAD+ metabolism by blocking the enzyme that degrades nicotinamide, enabling improved mitochondrial function and fat oxidation. Tesofensine is a triple monoamine reuptake inhibitor (serotonin, norepinephrine, dopamine) that reduces appetite through CNS modulation. The former works at the metabolic enzyme level; the latter at the neurotransmitter level. Fundamentally different mechanisms despite both being studied in metabolic research contexts.
- The difference between 5-Amino-1MQ and tesofensine becomes clearer when you examine what happens when NNMT is overexpressed versus when monoamine reuptake is uninhibited. Elevated NNMT activity depletes NAD+ by converting nicotinamide to N-methylnicotinamide, reducing the substrate available for NAD+ synthesis. This impairs mitochondrial respiration, reduces SIRT1 activity, and slows fat oxidation independent of caloric intake. Tesofensine doesn't touch this pathway. It extends the synaptic presence of serotonin, norepinephrine, and dopamine by blocking their transporters, which delays the hunger signal rebound that normally occurs 90–120 minutes post-meal. This article covers the distinct mechanisms of action, the research contexts where each compound is studied, and what those differences mean for selecting research-grade peptides.